|  | Prevalence | Unadjusted PR | Adjusted PR (aPR) | Wald Test |
---|---|---|---|---|---|
 | n | % (95% CI) | (95% CI) | (95% CI) | p value |
Hypertension | |||||
Gender | |||||
 Male | 394 | 11.1% (10.1–12.1) | reference | reference |  |
 Female | 732 | 16.4% (15.4–17.4) | 1.50 (1.34–1.64) | 1.36 (1.23–1.50) | < 0.001 |
Age | |||||
 18–39 years | 110 | 2.2% (1.8–2.7) | reference | reference |  |
 40–59 years | 504 | 24.0% (22.2–26.0) | 11.14 (8.91–13.94) | 10.45 (8.36–13.06) | < 0.001 |
 ≥60 years | 512 | 61.8% (58.5–65.1) | 28.69 (23.22–35.44) | 23.48 (18.87–29.23) |  |
Education | |||||
 None | 439 | 43.5% (40.2–46.8) | 5.74 (5.09–6.46) | 1.42 (1.25–1.61) |  |
 Primary | 299 | 15.8% (14.1–17.6) | 2.08 (1.80–2.40) | 1.31 (1.15–1.49) | < 0.001 |
 Secondary & higher | 388 | 7.6% (6.9–8.3) | reference | reference |  |
Location of residence | |||||
 Rural | 480 | 13.1% (12.0–14.3) | reference | reference |  |
 Urban | 646 | 14.8% (13.8–15.8) | 1.12 (1.01–1.26) | 1.07 (0.97–1.18) | 0.170 |
Diabetes (type I/II) | |||||
Gender | |||||
 Male | 275 | 7.7% (6.9–8.7) | reference | reference |  |
 Female | 465 | 10.4% (9.6–11.3) | 1.35 (1.18–1.53) | 1.22 (1.07–1.40) | 0.004 |
Age | |||||
 18–39 years | 61 | 1.2% (0.9–1.5) | reference | reference |  |
 40–59 years | 347 | 16.5% (15.0–18.3) | 13.84 (10.67–17.95) | 12.92 (9.93–16.81) | < 0.001 |
 ≥60 years | 332 | 40.1% (36.8–43.5) | 33.54 (26.03–43.22) | 26.89 (20.44–35.36) |  |
Education | |||||
 None | 288 | 28.5% (25.7–31.5) | 5.73 (4.89–6.70) | 1.48 (1.24–1.77) |  |
 Primary | 197 | 10.4% (9.0–12.0) | 2.08 (1.74–2.50) | 1.31 (1.10–1.56) | < 0.001 |
 Secondary & higher | 255 | 5.0% (4.4–5.6) | reference | reference |  |
Location of residence | |||||
 Rural | 314 | 8.6% (7.6–9.7) | reference | reference |  |
 Urban | 426 | 9.7% (8.9–10.7) | 1.13 (0.97–1.32) | 1.08 (0.94–1.25) | 0.286 |
Cardiovascular conditions | |||||
Gender | |||||
 Male | 200 | 5.6% (4.9–6.5) | reference | reference |  |
 Female | 256 | 5.7% (5.1–6.5) | 1.02 (0.86–1.21) | 0.93 (0.78–1.11) | 0.415 |
Age | |||||
 18–39 years | 57 | 1.1% (0.9–1.5) | reference | reference |  |
 40–59 years | 165 | 7.9% (6.7–9.2) | 7.04 (5.25–9.45) | 6.71 (4.98–9.04) | < 0.001 |
 ≥60 years | 234 | 28.3% (25.2–31.6) | 25.30 (19.01–33.68) | 21.44 (15.43–29.79) |  |
Education | |||||
 None | 177 | 17.5% (15.2–20.1) | 5.54 (4.55–6.75) | 1.38 (1.07–1.77) |  |
 Primary | 117 | 6.2% (5.1–7.5) | 1.95 (1.54–2.47) | 1.23 (0.98–1.54) | 0.038 |
 Secondary & higher | 162 | 3.2% (2.7–3.7) | reference | reference |  |
Location of residence | |||||
 Rural | 212 | 5.8% (5.0–6.7) | reference | reference |  |
 Urban | 244 | 5.6% (4.9–6.3) | 0.96 (0.79–1.17) | 0.91 (0.75–1.09) | 0.312 |
Chronic respiratory conditions | |||||
Gender | |||||
 Male | 99 | 2.8% (2.3–3.4) | reference | reference |  |
 Female | 158 | 3.5% (3.0–4.1) | 1.27 (0.98–1.66) | 1.19 (0.91–1.57) | 0.200 |
Age | |||||
 18–39 years | 117 | 2.3% (1.9–2.8) | reference | reference |  |
 40–59 years | 93 | 4.4% (3.6–5.4) | 1.93 (1.49–2.51) | 1.86 (1.43–2.43) | < 0.001 |
 ≥60 years | 47 | 5.7% (4.4–7.3) | 2.48 (1.82–3.37) | 1.98 (1.35–2.91) |  |
Education | |||||
 None | 61 | 6.0% (4.7–7.7) | 2.15 (1.62–2.85) | 1.46 (1.01–2.11) |  |
 Primary | 52 | 2.7% (2.0–3.7) | 0.97 (0.69–1.37) | 0.88 (0.62–1.23) | 0.052 |
 Secondary & higher | 144 | 2.8% (2.4–3.3) | reference | reference |  |
Location of residence | |||||
 Rural | 128 | 3.5% (2.9–4.2) | reference | reference |  |
 Urban | 129 | 3.0% (2.5–3.5) | 0.84 (0.65–1.08) | 0.84 (0.65–1.08) | 0.172 |